FDA Approved: DIFLUPREDNATE OPHTHALMIC — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved the original application for difluprednate ophthalmic from Sandoz, a corticosteroid eye drop for ocular inflammation associated with surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation of the Eye
• Postoperative Ocular Inflammation

Drugs mentioned

• Difluprednate ophthalmic (Difluprednate)

Snippet

ORIG AP for DIFLUPREDNATE OPHTHALMIC (DIFLUPREDNATE OPHTHALMIC)